Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Charles-Edouard Luyt and Karim Dorgham.
Charles-Edouard Luyt
Connection Strength
0.880
Karim Dorgham
  1. Distinct cytokine profiles associated with COVID-19 severity and mortality. J Allergy Clin Immunol. 2021 06; 147(6):2098-2107.
    View in: PubMed
    Score: 0.235
  2. Considering Personalized Interferon Beta Therapy for COVID-19. Antimicrob Agents Chemother. 2021 03 18; 65(4).
    View in: PubMed
    Score: 0.234
  3. Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia. J Clin Immunol. 2021 04; 41(3):536-544.
    View in: PubMed
    Score: 0.233
  4. CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2-infected patients. JCI Insight. 2021 09 22; 6(18).
    View in: PubMed
    Score: 0.061
  5. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
    View in: PubMed
    Score: 0.060
  6. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021 01 20; 13(577).
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.